跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,761 条关于
“SSc”
全部
2,761
临床试验
1,965
药物
527
机构
34
资讯
235
去年
SSc-ILD Market Projected to Reach $750 Million by 2034 as Novel Therapies Enter Pipeline
去年
Nintedanib Shows Sustained Efficacy in Slowing Lung Function Decline in SSc-ILD Patients Over Four Years
去年
aTyr Pharma's Efzofitimod Shows Promise in Pulmonary Sarcoidosis and SSc-ILD Trials
去年
Boehringer's Ofev Nears EU Approval for Systemic Sclerosis-Related Lung Disease
上个月
Liquidia's YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud's Phenomenon
去年
Zura Bio Launches Phase 2 TibuSURE Study of Tibulizumab for Systemic Sclerosis
去年
BioSenic Advances Autoimmune Pipeline and Explores Strategic M&A Opportunities
去年
CAR-T Therapy Shows Promise in Autoimmune Diseases with Minimal Toxicities
3个月前
Dual-Target CD19/BCMA CAR T-Cell Therapy Demonstrates Profound Remission in Refractory Systemic Sclerosis
2年前
Certa Therapeutics' GPR68 Inhibitor FT011 Receives International Non-Proprietary Name: Asengeprast
第 1 页,共 24 页
上一页
下一页